Legend Biotech Corp
LEGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001801198
In the last 90 days, Legend Biotech Corp insiders filed 0 open-market purchases and 3 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $3.03B in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Legend Biotech Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 3 filings
- 3 insiders, $220.7K in total
- Insiders trading
- 3
- Net value
- −$220.7K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Legend Biotech Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Santos Carlos E | Chief Financial Officer | 14,246 | Sep 23, 2026 | 1 |
| Zhang Ingrid | Chief Executive Officer | 1,131,860 | Sep 16, 2026 | 1 |
| Bash Alan | Interim CEO | 35,142 | Aug 18, 2026 | 1 |
| Casey Patrick John | Director | 48,604 | Jul 2, 2026 | 1 |
| Huang Ying | Chief Executive Officer | 238,490 | Jul 2, 2026 | 3 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 (view filing)4:15 PM ET | Sep 21 | 2 days | Santos Carlos EChief Financial Officer | SSale | −5.43K | $9.14 | −$49.6K | −27.6%14.2K after | |
| Jul 2, 2026 (view filing)4:05 PM ET | Jun 30 | 2 days | Casey Patrick JohnDirector | SSale | −6.00K | $14.80 | −$88.8K | −11.0%48.6K after | |
| Jun 29, 2026 (view filing) | Jun 25 | 4 days | Huang YingChief Executive Officer | SSale | −5.57K | $14.78 | −$82.3K | −2.2%241.9K after | |
| Mar 27, 2026 (view filing) | Mar 25 | 2 days | Huang YingChief Executive Officer | SSale | −9.94K | $8.77 | −$87.1K | −3.9%247.4K after |